| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRNX | Common Stock | Options Exercise | $80,467 | +6,700 | +81% | $12.01 | 15,011 | 19 Jan 2022 | Direct | F1, F2 |
| transaction | CRNX | Common Stock | Sale | $142,080 | -6,700 | -45% | $21.21 | 8,311 | 19 Jan 2022 | Direct | F1, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRNX | Non-qualified stock option (Right to Buy) | Options Exercise | $0 | -6,700 | -4% | $0.000000 | 160,473 | 19 Jan 2022 | Common stock | 6,700 | $12.01 | Direct | F1, F4 |
| Id | Content |
|---|---|
| F1 | The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date. |
| F2 | Includes 1,928 shares acquired under the Issuer's Employee Stock Purchase Plan since the last Section 16 filing by the Reporting Person. |
| F3 | Represents the weighted average sale price for the entire number of shares sold. The actual sales prices range between $20.77 and $21.68. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. |
| F4 | Stock option granted June 16, 2018 with 25% vesting on the first anniversary of the grant date and the remainder vesting in a series of thirty-six (36) successive equal monthly installments thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. |